Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHCPR physician practice guidelines

Executive Summary

Should include costs of alternative treatment options, the Physician Payment Review Commission recommends in its annual report submitted to Congress March 31. Noting concern that "the potential benefits of guidelines are being compromised by insufficient attention to how they can contribute to cost control as well as quality improvement," the report suggests that cost considerations be included in future guidelines "without requiring their developers to make value-laden decisions on trade-offs between costs and benefits of service to patients." Those trade- offs can then be assessed by the patient and his or her physician, PPRC Chairman Philip Lee, MD, suggested at a March 31 briefing. The HHS Agency for Health Care Policy and Research's first guidelines addressed treatments for urinary incontinence ("The Pink Sheet" March 30, p. 11) and pain management following surgery ("The Pink Sheet" March 9, p. 3).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS020643

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel